Michael James Newman

CSO and Director, Indaptus Therapeutics, Inc.

Companies

Indaptus Therapeutics, Inc.Board member Aug 6, 2021 to now¹
Indaptus Therapeutics, Inc.CSO and Director Aug 6, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Indaptus Therapeutics, Inc. INDP1,469,430 shares²$4.2M at $2.85Dec 22, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 22, 2025Granted 52,204 shares at $2.03 of Indaptus Therapeutics, Inc.²
Feb 1, 2022Sold 14,130 shares at $5.00 of Indaptus Therapeutics, Inc.³
Jan 31, 2022Sold 5,870 shares at $5.00 of Indaptus Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIndaptus Therapeutics, Inc., Board member
2
SEC EDGARIndaptus Therapeutics, Inc. shares after the filing of Dec 22, 2025
3
SEC EDGARForm 4 filed Feb 2, 2022